Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation De La Performance Clinique D'un Nouveau Biomarqueur Sanguin Des Phases Précoces De La Maladie De Parkinson

NCT05385315 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.

NCT NCT05385315
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05385315 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation De La Performance Clinique D'un Nouveau Biomarqueur Sanguin Des Phases Précoces De La Maladie De Parkinson
Lead sponsor
University Hospital, Grenoble
Phase
Observational
Overall status
Recruiting
Start date
October 13, 2022
Completion date
December 31, 2025
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease